GE Healthcare and IntrinsiQ Announce Collaboration to Link Clinical Oncology Information within Patient Electronic Medical Records

GE Healthcare, a leading provider of comprehensive clinical, financial and administrative information technology solutions, today announced an innovative collaboration with IntrinsiQ, LLC, a leading provider of cancer care software solutions, to seamlessly connect a cancer patient’s team of clinicians by providing oncology clinical information within that patient’s electronic medical record (EMR).

IntrinsiQ’s IntelliDose software fully automates the complex process of chemotherapy order entry and minimizes the potential for error by producing legible, complete and electronically checked orders. Interfacing these capabilities with GE’s Centricity® Electronic Medical Record solution will help provide users with information about patients undergoing chemotherapy, including drug administration records and nurse notes. The partnership will be unveiled this week at the 43rd annual meeting of the American Society of Clinical Oncology in Chicago.

“Merging yet another key piece of patient data within our Centricity EMR solution demonstrates our commitment to providing comprehensive clinical information systems for our providers and their patients,” said Stephen Gorman, vice president and general manager for GE Healthcare Integrated IT Solutions.

Administration of chemotherapy requires precision and accuracy in a busy clinical setting. According to Bill Wisotzkey, General Manager for IntrinsiQ’s IntelliDose Solutions, IntrinsiQ’s technology can help automate this process while offering tools for error checking --ultimately helping to improve overall patient safety.

Studies have shown that chemotherapy errors can be traced to a variety of issues related to human error, procedural flaws and lack of standardization. “IntelliDose is designed to help automate the administration of chemotherapy using practice-specific standards including automated error checking features that meet the recommendations of the Institute of Medicine report for safe medical practice,” said Wisotzkey.

“Previously chemotherapy treatment was calculated and documented using pen and paper,” said Simeon Schwartz, MD, chief executive officer of Westchester Medical Group. “Not only was this extremely inefficient but more importantly it could lead to potential human error. By interfacing our Centricity EMR system with the Intellidose software, our practice has virtually gone from the Flintstones to the Jetsons in a matter of weeks.”

“We’re thrilled to offer the IntelliDose product suite within one of the industry’s leading EMR systems to help us improve overall patient care,” said Wisotzkey. “Bringing comprehensive patient information to the clinicians’ fingertips along with the IntrinsiQ tools and alerts to assist them in better decision making is how the combination of medicine and information technology will transform today’s healthcare system.”

ABOUT GE HEALTHCARE

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

About IntrinsiQ, LLC

IntrinsiQ, LLC is the leading provider of workflow solutions to the oncology physician market and premier source of US Oncology data and analysis. The IntelliDose product suite provides oncology physicians with a clinical information system that delivers patient safety though automation and standards built specifically to meet the needs of a specific practice. Only IntelliDose supports end-to-end care of cancer patients maintaining patient safety, saving staff time, maximizing reimbursement and reducing operating costs.

IntrinsiQ, LLC has created an unrivaled database of accurate, detailed and timely information about medical oncology care process. The database is the foundation of products and services designed to uniquely address the business issues and decisions of the pharmaceutical product manager, market researcher and financial analyst. For more information, please visit our websites www.intrinsiq.com and www.intellidose.com or call 781-647-1144.